<PAGE>
Rule 497(d)
Reg. No. 333-96413
National Equity Trust
Biotech Securities Trust
Supplement to Prospectus dated July 7, 2000
Sales charge:
After the first Deferred Sales Charge Deduction Date, as the Deferred Sales
Charge ("DSC") declines the Initial Sales Charge will increase so that the
remaining DSC in the first year and the Initial Sales Charge will total 3% of
the Public Offering Price.. Unit Holders holding Units on the Second Year
Commencement Date will be charged an additional Deferred Sales Charge of $20.00
per 1,000 Units, payable at the rate of $2.00 per 1,000 Units for the first 10
months in the second year of the Trust. The Initial Sales Charge and the DSC
payable over two years will equal 5% of the Public Offering Price.
